XML 50 R19.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Equity (Deficit) (Tables)
12 Months Ended
Dec. 31, 2019
Summary of Unvested Shares

A summary of the Company’s unvested shares is as follows (in thousands):

 

 

 

Number of

Shares

 

Balance at December 31, 2018

 

 

100

 

Vested shares

 

 

(65

)

Balance at December 31, 2019

 

 

35

 

Summary of Stock Option Outstanding, Vested and Expected to Vest and Exercisable

 

 

 

Number of

Shares

 

 

Weighted-

Average

Exercise

Price

 

 

Weighted-

Average

Remaining

Contractual

Term

(in years)

 

 

Aggregate

Intrinsic

Value

 

December 31, 2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options outstanding

 

 

1,662,253

 

 

$

4.17

 

 

 

9.2

 

 

$

1,460

 

Options vested and expected to vest

 

 

1,662,253

 

 

$

4.17

 

 

 

9.2

 

 

$

1,460

 

Options exercisable

 

 

244,170

 

 

$

1.16

 

 

 

7.2

 

 

$

718

 

 

Summary of Stock Option Activity

A summary of the Company’s stock option activity under the 2019 Plan and 2015 Plan is as follows:

 

 

 

Number of

Options

 

 

Weighted-

Average

Exercise

Price

 

Balance at December 31, 2018

 

 

504,019

 

 

$

0.81

 

Granted

 

 

1,230,000

 

 

$

5.47

 

Cancelled

 

 

(52,726

)

 

$

3.38

 

Exercised

 

 

(19,040

)

 

$

0.69

 

Balance at December 31, 2019

 

 

1,662,253

 

 

$

4.17

 

Summary of Share-Based Compensation Expense

Stock-based compensation expense recognized for all equity awards has been reported in the statements of operations as follows (in thousands):

 

 

 

Years Ended

December 31,

 

 

 

2019

 

 

2018

 

Research and development

 

$

237

 

 

$

141

 

General and administrative

 

 

270

 

 

 

39

 

 

 

$

507

 

 

$

180

 

Common Stock Reserved for Future Issuance

Common stock reserved for future issuance is as follows (in thousands):

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Redeemable convertible preferred stock

 

 

 

 

 

8,148

 

Warrants to purchase convertible preferred stock

 

 

 

 

 

372

 

Common stock warrants

 

 

841

 

 

 

 

Common stock options issued and outstanding

 

 

1,958

 

 

 

504

 

Common stock available for issuance under equity

   plans

 

 

495

 

 

 

80

 

 

 

 

3,294

 

 

 

9,104

 

Stock Option Grants  
Schedule of Assumptions Used to Determine Fair Value

The weighted-average assumptions used in the Black-Scholes option pricing model to determine the fair value of stock option grants were as follows:

 

 

 

Years Ended

December 31,

 

 

 

2019

 

 

2018

 

Risk-free interest rate

 

 

1.6

%

 

 

2.9

%

Expected volatility

 

 

77.6

%

 

 

64.7

%

Expected term (in years)

 

 

6.0

 

 

 

6.1

 

Expected dividend yield

 

 

%

 

 

%